CHESAPEAKE ASSET MANAGEMENT LLC

Position in MRK — Merck & Co., Inc.

CIK 1079397 NEW YORK, NY

Position in MRK

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$2,055,871

+$245,146 QoQ

Shares Held

15,999

+6.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.49%

of 13F equity value

Holder Rank

#1,570

of 3,766 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CHESAPEAKE ASSET MANAGEMENT LLC holds $16,421,292 across 10 Drug Manufacturers - General names. MRK ranks #2 (12.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	9,659	$11,585,295
2	MRK	Merck & Co., Inc. This page	15,999	$2,055,871
3	ABBV	AbbVie Inc.	5,763	$1,450,201
4	JNJ	Johnson & Johnson	4,549	$1,155,309
5	PFE	Pfizer Inc	4,008	$96,512
6	BMY	Bristol Myers Squibb Co	972	$56,006
7	GSK	GSK plc	248	$13,000
8	AZN	Astrazeneca PLC	37	$7,015

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,055,871	15,999	+6.3%	Shares	Sole	2026-08-04
2026-03-31	$1,810,725	15,053	-6.9%	Shares	Sole	2026-05-12
2025-12-31	$1,701,633	16,166	-5.7%	Shares	Sole	2026-01-08
2025-09-30	$1,439,399	17,150	-31.9%	Shares	Sole	2025-10-17
2025-06-30	$1,994,357	25,194	-1.2%	Shares	Sole	2025-10-15
2025-03-31	$2,289,777	25,510	-11.9%	Shares	Sole	2026-01-05
2024-12-31	$2,879,150	28,942	+0.1%	Shares	Sole	2026-01-05
2024-09-30	$3,282,111	28,902	-9.3%	Shares	Sole	2026-01-05
2024-06-30	$3,944,515	31,862	-0.7%	Shares	Sole	2026-01-05
2024-03-31	$4,231,900	32,072	-17.7%	Shares	Sole	2026-01-05
2023-12-31	$4,250,798	38,991	+0.7%	Shares	Sole	2026-01-05
2023-09-30	$3,987,459	38,732	-7.5%	Shares	Sole	2026-01-05
2023-06-30	$4,832,533	41,880	-6.3%	Shares	Sole	2026-01-05
2023-03-31	$4,752,866	44,674	—	Shares	Sole	2026-01-05
No filing history on record for this holder in this stock.